Testosterone Propionate
People mainly take Testosterone Propionate for performance, libido. Based on 2 first-hand reports. Ranked #1368 of 1,974 overall.
14
User score
Mostly positive50% positive0% mixed0% negative50% unclear
Of reports that state an outcome, 100% are positive.
Clinical research
Research pending
High-risk compound. SARMs are not approved as supplements, carry serious and sometimes irreversible risks, are banned in competitive sport and may be restricted where you live. Nothing here is a recommendation to use it.
What Testosterone Propionate does, according to users
Of the people who reported each effect, the share who said it got better.
betterno changeworse
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
Research data for Testosterone Propionate is being compiled.
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
100 mgevery other day
Reported side effects
How often each side effect came up across all reports.
No side effects reported so far.
What users say
Verbatim quotes, shortened only — each links to the original discussion.
“Testosterone propionate 100mg EOD”
“Testosterone propionate”
Other options for performance
Resistance Training
Lifestyle · 53 reports
100% report better performance
Mostly positive
Retatrutide
Peptide · 298 reports
92% report better performance
Mostly positiveBResearch: Moderate
Tirzepatide
Medication · 219 reports
88% report better performance
Mostly positiveAResearch: Strong
Creatine Monohydrate
Supplement · 139 reports
96% report better performance
Mostly positiveAResearch: Strong
Magnesium Malate
Supplement · 103 reports
100% report better performance
Mostly positiveDResearch: None
Semaglutide
Medication · 137 reports
80% report better performance
Mostly positiveAResearch: Strong
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate